Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl

  title={Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl},
  author={H-H B{\"u}low and Michael U. S. Linnemann and H Berg and Torsten Lang-Jensen and Stephen LaCour and Torsten Jonsson},
  journal={Acta Anaesthesiologica Scandinavica},
This study made a longterm (72 hours) evaluation of the efficacy and possible side‐effects of transdermal delivery of fentanyl (TTS‐system) for post‐operative pain relief. 

Paper Mentions

Interventional Clinical Trial
The choice of the sedation protocol has a massive impact on the duration of mechanical ventilation and the timing of extubation. Many sedation protocols are described in the… Expand
ConditionsAnalgesics, Opioid, Respiratory Insufficiency, Ventilator Weaning
Pharmacokinetic Profile and Efficacy of a Fentanyl Transdermal Delivery System for Acute Postoperative Pain after Intra‐abdominal Gynecologic Surgery for Cancer
Purpose:  This prospective, randomized, single‐blind study evaluated the efficacy and pharmacokinetic profile of a transdermal delivery system for fentanyl to provide relief of acute postoperativeExpand
Severe respiratory depression and sedation with transdermal fentanyl: four case studies
Four patients with advanced cancer on transdermal (TD) fentanyl (Durogesic) develop delayed and severe respiratory depression and these cases are of concern since past and recent studies have suggested that respiratory depression with TD fentanyl is uncommon and mild. Expand
Management of the Postoperative Pain
In recent years many advances have been made in understanding the patho-physiology and the neural pathways of pain, as well as in developing new analgesic drugs and new routes of administration.
Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain
Transdermal fentanyl is indicated only for patients who require continuous opioid administration for the treatment of chronic pain that cannot be managed with other medications, as pain may decrease more rapidly in these circumstances than fentanyl blood levels can be adjusted, leading to the development of life-threatening hypoventilation. Expand
Efficacy and safety of transdermal fentanyl in the control of postoperative pain after photorefractive keratectomy.
Evaluating the efficacy and safety of transdermal fentanyl in the control of postoperative pain following photorefractive keratectomy (PRK) found differences in mean pain intensity scores were significant between the control group and the fentanyl group. Expand
Transdermal therapeutic fentanyl-system (TTS-F).
The transdermal therapeutic fentanyl-system (TTS-F) allows for a continued and sustained titratable amount of fentanyl to be delivered without the inconvenience of the typical 24-h administration of other analgesics. Expand
Transdermal fentanyl patch for postoperative analgesia in total knee arthroplasty: a randomized double-blind controlled trial
TFP (50 μg/hour) applied 10–12 hours before surgery can effectively and safely decrease morphine consumption and pain scores during the first 48 hours after TKA surgery. Expand
Transdermal fentanyl as an adjuvant to paravertebral block for pain control after breast cancer surgery: A randomized, double-blind controlled trial
TFPs releasing 25 μg/h is a safe and effective adjuvant to PVB after breast cancer surgery that provides adequate analgesia with reduction of opioid consumption and minimal adverse effects. Expand
Opioids, respiratory function, and dyspnea
Current knowledge in the pathophysiology of dyspnea, proposed opioid mechanism of action, and evidence of efficacy are reviewed. Expand
Transdermal Fentanyl
Transdermal fentanyl is a useful alternative to other opioid agents, which is also recommended on the third step of the WHO analgesic ladder, in the management of chronic malignant pain and preliminary data indicate that it may be useful in themanagement of chronic nonmalignant pain. Expand


Transdermal fentanyl for the relief of pain after upper abdominal surgery.
Transdermal fentanyl was compared with placebo in a double-blind study of pain after upper abdominal surgery and pain scores were significantly lower and peak expiratory flow rates significantly higher in the transdermalentanyl group, who demanded significantly less morphine than the control group. Expand
The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems
There was no significant difference between the patients in the T TS‐fentanyl and TTS‐placebo groups in the VAPS throughout the 0–12, 12–24, 24–36 and 36–48 h periods suggesting that the quality of pain relief was similar between the 2 groups. Expand
The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects
The TTS‐fentanyl systems provided a significant contribution to postoperative pain control but, at the TTS dose rates used, supplementary doses of pethidine were required by all patients probably to control ‘incident’ pain. Expand
Transdermal fentanyl for postoperative pain management. A double-blind placebo study.
The incidence of vomiting, respiratory rate, and respiratory rate in the active group was lower than in the placebo group during the 13- to 24-hour interval of system application, and transdermal fentanyl appears to be safe and effective after orthopedic surgery in healthy adult patients. Expand
Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery.
Serum concentrations of fentanyl increased slowly (15 h to plateau) and decreased slowly (apparent half-life, 21 h) and it is concluded that delivery of analgesic doses of fentanyl is feasible by the transdermal route. Expand
Late postoperative nocturnal episodic hypoxaemia and associated sleep pattern.
It is concluded that postoperative sleep pattern is disturbed severely with early depression of REM and slow wave sleep and with rebound of REM sleep on the second and third nights. Expand
Kehlet H . Late postoperative nocturnal episodic hypoxdemia and associated sleep pattern
  • BrJAnaesth
  • 1994
Experience with Transdermal Fentanyl in advanced cancer pain
  • EurJPuin
  • 1990
: pharmacokinetics and pharmacodynamic effects
  • 1989